1. Home
  2. LXRX vs FET Comparison

LXRX vs FET Comparison

Compare LXRX & FET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.38

Market Cap

703.3M

Sector

Health Care

ML Signal

HOLD

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

HOLD

Current Price

$48.93

Market Cap

645.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXRX
FET
Founded
1995
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
703.3M
645.5M
IPO Year
2000
2007

Fundamental Metrics

Financial Performance
Metric
LXRX
FET
Price
$2.38
$48.93
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.15
N/A
AVG Volume (30 Days)
4.1M
155.2K
Earning Date
05-01-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
77.78
92.64
EPS
N/A
0.39
Revenue
$49,803,000.00
$791,474,000.00
Revenue This Year
N/A
$7.35
Revenue Next Year
N/A
$6.95
P/E Ratio
N/A
$128.79
Revenue Growth
60.24
N/A
52 Week Low
$0.87
$18.12
52 Week High
$2.68
$65.43

Technical Indicators

Market Signals
Indicator
LXRX
FET
Relative Strength Index (RSI) 60.77 39.04
Support Level $1.52 $48.03
Resistance Level $2.53 $62.98
Average True Range (ATR) 0.15 2.21
MACD 0.05 0.04
Stochastic Oscillator 63.69 26.26

Price Performance

Historical Comparison
LXRX
FET

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a manufacturing company serving the oil, natural gas, industrial, and renewable energy industries. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. The company operates in two reportable segments: Drilling and Completions, and Artificial Lift and Downhole. Maximum revenue is generated from the Drilling and Completions segment, which offers products used in the drilling process, and other products like hydraulic fracturing pumps, ROVs and trenchers, submarine rescue vehicles, etc. Geographically, the firm generates maximum revenue from the U.S., followed by Canada, Middle East, Europe and Africa, Asia-Pacific, and Latin America.

Share on Social Networks: